Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Elderberry juice rich in anthocyanins boosts glucose regulation and fat metabolism, with significant effects on gut ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

A fat activist explains why she objects to the medicalization of larger bodies and the idea that obesity is a disease.

The negative impact of obesity on prognosis was especially pronounced in patients with acute lymphoblastic leukemia and brain ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

"Alison was the preeminent scholar on adolescent obesity and eating disorders,” said Kerri Boutelle, a pediatrics professor ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Breaking the silence on how generational trauma impacts obesity in Black communities, through one woman's powerful journey ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence ...